Institutional Ownership
Coeptis Therapeutics Hldgs I
CUSIP 19207A116*W EXP 10/28/202COEPWQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
10
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Rivernorth Capital Management, LLC | 148.0K | $1.7K |
| 2 | Meteora Capital, LLC | 114.9K | $1.3K |
| 3 | Walleye Trading LLC | 79.9K | $927 |
| 4 | Toronto Dominion Bank | 44.7K | $537 |
| 5 | Ubs Group AG | 23.2K | $279 |
| 6 | Two Sigma Securities, LLC | 20.4K | $237 |
| 7 | Hunting Hill Global Capital, LLC | 16.4K | $190 |
| 8 | Clear Street Group Inc. | 4.9K | $57 |
| 9 | Wells Fargo & Company/Mn | 100 | $1 |
| 10 | Skyview Investment Advisors, LLC | 50.1K | $1 |